CRISPR

A Basel, Switzerland and Boston, MA-based biopharmaceutical company created to translate CRISPR-Cas9, a breakthrough genome-editing technology, into transformative medicines with the potential to cure serious human genetic diseases

CRISPR operates in healthcare.

The company sits in the healthcare segment, where it competes on its core product or service.

Its current recorded stage is 2015Growth.

Website: crisprtx.com